Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 3.25x is 57% below its 5-year average of 7.55x, around the middle of its 5-year range (-77.91x–66.50x).
As of the fiscal period ended Tuesday, December 31, 2013. 60.98% below its 12-month average of 8.33x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2013 (2013-12-31): 3.25x.
INTEREST COVERAGE RATIO
3.25x
INTEREST COVERAGE RATIO AVG TTM
8.33x
INTEREST COVERAGE RATIO AVG 3Y
8.89x
INTEREST COVERAGE RATIO AVG 5Y
7.55x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-60.98%
CURRENT VS 3Y AVG
-63.41%
CURRENT VS 5Y AVG
-56.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.92x
median of 412 covered companies
CURRENT VS SECTOR MEDIAN
+166.09%
vs the sector median at left
IRIDEX Corporation
Market Cap
$12.63M
Interest Coverage Ratio
3.25x
TTM Avg
8.33x
3Y Avg
8.89x
5Y Avg
7.55x
Market Cap
$12.48M
Interest Coverage Ratio
-16.47x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.17M
Interest Coverage Ratio
-8.52x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.27M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.29M
Interest Coverage Ratio
-5.45x
TTM Avg
0.92x
3Y Avg
0.92x
5Y Avg
0.92x
Market Cap
$11.78M
Interest Coverage Ratio
-1171.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.72M
Interest Coverage Ratio
-18.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRIDEX Corporation (IRIX) | $12.63M | 3.25x | 8.33x | 8.89x | 7.55x |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | -16.47x | N/A | N/A | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.17M | -8.52x | N/A | N/A | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $12.27M | N/A | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.06M | N/A | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $13.29M | -5.45x | 0.92x | 0.92x | 0.92x |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.78M | -1171.55x | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.62M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | -18.73x | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG)vs › | $13.78M | N/A | N/A | N/A | N/A |
Interest Coverage
3.3x
Debt/Equity
1.10
Current Ratio
1.82
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2013-12-31 | 3.25x |
| 2013-09-28 | 7.82x |
| 2013-06-29 | 5.31x |
| 2012-12-31 | 16.94x |
| 2012-09-29 | -4.95x |
| 2012-06-30 | -7.29x |
| 2011-12-31 | 5.80x |
| 2011-10-01 | 9.74x |
| 2011-04-02 | 11.77x |
| 2010-12-31 | 40.48x |
| 2010-10-02 | 14.05x |
| 2010-07-03 | 2.70x |
| 2010-04-03 | 9.73x |
| 2009-12-31 | 19.68x |
| 2009-10-03 | 15.14x |
| 2009-07-04 | 66.50x |
| 2009-04-04 | 3.63x |
| 2008-12-31 | -77.91x |
| 2008-09-27 | -4.26x |
| 2008-06-28 | -1.17x |
| 2008-03-29 | -4.79x |
| 2007-12-31 | -383.34x |
| 2007-09-29 | -5.73x |
| 2007-06-30 | -8.70x |
